Dynamic QuantiFERON Response in Psoriasis Patients Taking Long-Term Biologic Therapy.
作者： Lorenzo Drago , Lucia Nicola , Valentina Signori , Elisa Palazzi , Cecilia Garutti
DOI: 10.1007/S13555-013-0020-3
关键词:
摘要: Introduction The risk of active tuberculosis is increased in psoriasis patients receiving biologic drug therapy. The QuantiFERON-TB Gold In-Tube assay (QFT) used for latent screening these patients. This study presents a retrospective analysis on repeated QFT assays, investigating the influence drugs and isoniazid therapy outcome assay.
springer.com
core.ac.uk
elsevier.com
paperity.org
researchgate.net 参考文章(34)
H‐Y Chiu, P‐R Hsueh, T‐F Tsai, None, Clinical experience of QuantiFERON(®) -TB Gold testing in patients with psoriasis treated with tumour necrosis factor blockers in Taiwan. British Journal of Dermatology. ,vol. 164, pp. 553- 559 ,(2011) , 10.1111/J.1365-2133.2010.10137.X
F. González-Salazar, J. Vargas-Villarreal, F.J. Garcialuna-Martínez, G. Rivera, M.G. Moreno-Treviño, J.M. Montfort-Gardeazabal, E. Garcialuna-Martínez, Snapshot of Quantiferon TB gold testing in Northern Mexico Tuberculosis. ,vol. 91, ,(2011) , 10.1016/J.TUBE.2011.10.007
Yoshihiro Kobashi, Keiji Mouri, Shinich Yagi, Yasushi Obase, Naoyuki Miyashita, Niro Okimoto, Toshiharu Matsushima, Takeshi Kageoka, Mikio Oka, Clinical utility of the QuantiFERON TB-2G test for elderly patients with active tuberculosis. Chest. ,vol. 133, pp. 1196- 1202 ,(2008) , 10.1378/CHEST.07-1995
Kazue HIGUCHI, Nobuyuki HARADA, Toru MORI, Interferon‐γ responses after isoniazid chemotherapy for latent tuberculosis Respirology. ,vol. 13, pp. 468- 472 ,(2008) , 10.1111/J.1440-1843.2008.01244.X
Jemianne Bautista, Niaz Banaei, Sensitivity of QuantiFERON-TB GOLD In-Tube for diagnosis of recent versus remote M. tuberculosis infection. Diagnostic Microbiology and Infectious Disease. ,vol. 73, pp. 257- 259 ,(2012) , 10.1016/J.DIAGMICROBIO.2012.03.018
Julián Panés, Fernando Gomollón, Carlos Taxonera, Joaquin Hinojosa, Juan Clofent, Pilar Nos, Crohn's Disease : A Review of Current Treatment with a Focus on Biologics Drugs. ,vol. 67, pp. 2511- 2537 ,(2007) , 10.2165/00003495-200767170-00005
Sonia Mínguez, Irene Latorre, Lourdes Mateo, Alicia Lacoma, Jéssica Diaz, Alejandro Olivé, Jose Domínguez, Interferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatment. Clinical Rheumatology. ,vol. 31, pp. 785- 794 ,(2012) , 10.1007/S10067-012-1938-Z
Madhukar Pai, Alice Zwerling, Dick Menzies, Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Annals of Internal Medicine. ,vol. 149, pp. 177- 184 ,(2008) , 10.7326/0003-4819-149-3-200808050-00241
W. Sterry, J. Barker, W.-H. Boehncke, J.D. Bos, S. Chimenti, E. Christophers, M. De La Brassinne, C. Ferrandiz, C. Griffiths, A. Katsambas, K. Kragballe, C. Lynde, A. Menter, J.-P. Ortonne, K. Papp, J. Prinz, B. Rzany, J. Ronnevig, J.-H. Saurat, M. Stahle, F.M. Stengel, P. Van De Kerkhof, J. Voorhees, Biological therapies in the systemic management of psoriasis: International Consensus Conference. British Journal of Dermatology. ,vol. 151, pp. 3- 17 ,(2004) , 10.1111/J.1365-2133.2004.06070.X
Ajit Lalvani, Kerry A. Millington, Screening for tuberculosis infection prior to initiation of anti-TNF therapy Autoimmunity Reviews. ,vol. 8, pp. 147- 152 ,(2008) , 10.1016/J.AUTREV.2008.07.011